Nutrien Sees Consensus Price Target Improvement Following Raised Guidance

On June 21st, Nutrien (TSX: NTR) raised their first half 2021 earnings per share guidance by $0.30 to $2.30 to $2.50 and announced that since the potash market has continued to tighten, they have upgraded capacity. They expect an additional half-million tonnes of potash of production output, after the June 7th half million tonne increase. These increases bring their expected potash sales volume to 13.3 – 13.8 million tonnes.

Off this news, a few analysts raised their 12-month price target on Nutrien, bringing their consensus 12-month price target to $66.71, up from $64.89, based on 20 analysts. Of those 20, three analysts have strong buy ratings, 13 have buy ratings, three have hold ratings and one analyst has a sell rating. The street high comes from Raymond James with an $82 price target and the lowest sits at $58 from Atlantic Equities.

BMO Capital Markets raised their 12-month price target to $70, from $65, and reiterated their outperform rating, calling this the dream scenario for Nutrien. The main reason for the raise is BMO marking-to-market their model for the recent fertilizer price surges and increased volume guidance by Nutrien. They believe that the average price now sits between $25-$70 per tonne but writes, “While we don’t see spot Brazil potash, NOLA urea, and Tampa DAP holding $500/t, $450/st or $660/t (all decade highs), we see prices still ending 2021E strong with Q4E averages of $425/t, $330/st and $520/t respectively.”

BMO believes that Nutrien can fill the gap for sanctions against Belarusian potash. They write, “We surmise NTR wants to make sure stakeholders understand NTR has much excess capacity in case the EU wants to really target Lukashenko.”

Below you can see BMO’s updated second quarter, 2021 and 2022 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Story Starts With Cash Flow | Gordon Robb – ESGold

Silverco Cusi Mine PEA: Bigger Isn’t Always Better

Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley – Cardiol Therapeutics

Recommended

Cambria Drills 17.95 g/t Gold Over 22 Metres At Premier Mine

Denarius Metals Increases Bid For Emerita Resources To $0.45 Per Share

Related News

Ayr Wellness: Canaccord Raises Price Target To $70

On March 10th, Ayr Wellness (CSE: AYR.a) reported their fourth quarter and year end financial...

Sunday, March 14, 2021, 02:41:00 PM

Eldorado Gold’s Q2 Production Comes Up Short For BMO’s Estimates

Eldorado Gold (TSX: ELD) earlier this week announced its second-quarter production results. The company announced...

Saturday, July 16, 2022, 03:14:00 PM

Cognetivity Neurosciences: Echelon Initiates Coverage With $0.85 Price Target

On Friday, Echelon Capital Markets initiated coverage on Cognetivity Neurosciences (CSE: CGN) with a speculative...

Monday, April 19, 2021, 10:36:00 AM

Trulieve: Canaccord Retains $97 Price Target Following Harvest Health Transaction

On October 1, Trulieve Cannabis (CSE: TRUL) announced that they completed their $1.75 billion acquisition...

Sunday, October 10, 2021, 01:03:00 PM

Lundin Mining: BMO Maintains $13.00 Price Target Following Chapada Resumption

Yesterday Lundin Mining (TSX: LUN) announced that they had resumed full production at their Chapada...

Tuesday, December 22, 2020, 11:51:00 AM